Yeah. True and same here. As a student of outliers and clusters more than the symmetric of a bell curve just curious that is all...
- Forums
- ASX - By Stock
- Ann: First patient treated in the Phase II of the SECuRE trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
2.68%
!
$2.18

Yeah. True and same here. As a student of outliers and clusters...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.18 |
Change
-0.060(2.68%) |
Mkt cap ! $700.5M |
Open | High | Low | Value | Volume |
$2.24 | $2.28 | $2.17 | $3.806M | 1.722M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 52794 | $2.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.20 | 13567 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 52794 | 2.180 |
3 | 19000 | 2.170 |
10 | 83424 | 2.160 |
5 | 26899 | 2.150 |
4 | 18119 | 2.140 |
Price($) | Vol. | No. |
---|---|---|
2.200 | 13567 | 3 |
2.210 | 28907 | 1 |
2.220 | 7456 | 1 |
2.230 | 39476 | 3 |
2.240 | 23366 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online